Ticker | GM |
Earnings Date | July 21, 2026 — 8:30 AM ET (Before Open) |
Reporting Period | Q2 2026 (quarter ended June 30, 2026) |
Prepared | July 20, 2026 |
Last Earnings | April 28, 2026 (Q1 2026) |
Key Takeaway: The setup is modestly constructive — consensus has been revised up since Q1 and the bar is achievable, but the biggest swing factor is how much of the Iran conflict’s commodity and freight cost headwind hit Q2 margins.
Bar: Consensus EBIT-adjusted for Q2 2026 sits at approximately $3.9–4.0B, a step down from Q1’s $4.3B beat (which included a one-time ~$0.5B IIPA tariff adjustment). Stripping that benefit, Q1’s underlying EBIT was ~$3.8B, making the Q2 bar achievable but not easy. EPS-diluted-adjusted consensus is ~$3.20, implying the Street expects solid but not exceptional execution. North America EBIT margin is the key KPI to watch — management guided 8–10% for the full year, and Q2 will be the first clean read without the tariff accounting benefit.
Guidance/Tone: Management raised full-year EBIT-adjusted guidance to $13.5–15.5B at Q1 earnings (from $13–15B), but explicitly flagged the Iran conflict as the “#1 thing we’re watching,” citing oil price impacts on logistics and commodity costs. Tone is cautiously confident — the company is executing its plan but has declined to raise guidance further until the conflict’s duration and cost impact become clearer. Commodity/logistics inflation guidance was raised to $1.5–2.0B for the full year, with the incremental $500M expected to be equally weighted across Q2–Q4.
Estimate Trajectory: EPS estimates for Q2 2026 dipped sharply in April–May (from ~$3.16 to ~$2.35) as the market digested Iran conflict uncertainty and commodity cost headwinds, then partially recovered to ~$2.68 by July. The recovery suggests the Street has partially priced in the headwinds but has not fully re-rated to the upside — creating a modest cushion if GM executes in line with its own guidance.
Stock Setup: GM is down ~3.6% since Q1 earnings (vs. CARZ +4.6%, S&P 500 +4.4%), trading at just ~5.6x NTM P/E. The stock has underperformed the auto ETF and the market, suggesting the Iran/commodity overhang is already partially discounted. A clean Q2 print with no guidance cut would likely be a positive catalyst; any further guidance reduction would be punished.
Wildcard: The Iran conflict remains the single biggest unknown. Management guided commodity/logistics inflation of $1.5–2.0B for the full year assuming current commodity prices persist — any escalation or de-escalation in the conflict could meaningfully move that figure and drive a guidance revision in either direction. Additionally, the timing of the IIPA tariff refund (excluded from FCF guidance) represents potential upside surprise to free cash flow.
Key Takeaway: Consensus is a moderate bar — not stretched, but not low.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | FY 2026 Guidance | Consensus vs. Guidance Midpoint |
Total Revenue ($B) | $43.6B | $47.1B | $46.7B | -0.9% YoY | ~$185.3B (consensus FY) | N/A — no explicit revenue guidance |
EPS-Diluted-Adjusted ($) | $3.70 | $2.53 | $3.20 | +26.5% YoY | $11.50–$13.50 (mid: $12.50) | ~+2.9% above midpoint (FY consensus $12.86) |
GMNA EBIT-Adjusted ($B) | $3.66B (10.1% margin) | $2.42B | $3.23B | +33.6% YoY | 8–10% NA margin (FY) | N/A — no explicit quarterly EBIT guidance |
Adj. Auto Free Cash Flow ($B) | $1.27B | $2.83B | $3.57B | +26.2% YoY | $9.0–$11.0B (mid: $10.0B) | FY consensus $8.5B — ~15% below midpoint |
GMNA Wholesale Units (K) | 793K | 849K | 838K | -1.3% YoY | Flat to modestly up (ICE); EV lower | N/A |
Source: Visible Alpha Consensus and Actuals Data; GM Q1 2026 Earnings Release (April 28, 2026); GM Q1 2026 Earnings Call Transcript.
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q1 2026 | EPS-Diluted-Adj. | $3.70 | $2.61 | +41.8% | BEAT |
Q1 2026 | GMNA EBIT-Adj. | $3.66B | $2.32B | +57.8% | BEAT |
Q4 2025 | EPS-Diluted-Adj. | $2.51 | $2.26 | +11.1% | BEAT |
Q4 2025 | GMNA EBIT-Adj. | $2.24B | $2.24B | 0.0% | IN LINE |
Q3 2025 | EPS-Diluted-Adj. | $2.80 | $2.25 | +24.4% | BEAT |
Q3 2025 | GMNA EBIT-Adj. | $2.51B | $2.08B | +20.7% | BEAT |
Q2 2025 | EPS-Diluted-Adj. | $2.53 | $2.34 | +8.1% | BEAT |
Q2 2025 | GMNA EBIT-Adj. | $2.42B | $2.49B | -3.0% | MISS |
Q1 2025 | EPS-Diluted-Adj. | $2.78 | $2.70 | +3.1% | BEAT |
Q1 2025 | GMNA EBIT-Adj. | $3.29B | $3.20B | +2.7% | BEAT |
Q4 2024 | EPS-Diluted-Adj. | $1.92 | $1.78 | +7.9% | BEAT |
Q4 2024 | GMNA EBIT-Adj. | $2.27B | $2.64B | -14.0% | MISS |
Q3 2024 | EPS-Diluted-Adj. | $2.96 | $2.15 | +37.7% | BEAT |
Q3 2024 | GMNA EBIT-Adj. | $3.98B | $3.12B | +27.6% | BEAT |
Pattern: GM has beaten EPS-diluted-adjusted consensus in 7 of the last 8 quarters, often by wide margins. GMNA EBIT-adjusted beats are less consistent — GM missed in Q4 2024 and Q2 2025 — suggesting North America margin execution is the more volatile and harder-to-predict KPI heading into Q2 2026.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Q2 2026 EPS estimates fell sharply post-Q1 earnings as the Iran conflict and commodity cost headwinds were digested, then partially recovered. FY 2026 estimates have held near the raised guidance midpoint, suggesting the Street believes GM can deliver on its full-year target despite Q2 headwinds.
KPI / Period | Estimate (May 5, 2026 — ~5 Days Post Q1 Print) | Current Consensus (Jul 20, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
EPS-Diluted-Adj. — Q2 2026 | $3.18 | $3.20 | +0.6% | No explicit Q2 guidance | No explicit Q2 guidance | N/A | N/A |
EPS-Diluted-Adj. — FY 2026 | $12.79 | $12.86 | +0.5% | $11.50–$13.50 | $11.50–$13.50 (unchanged) | 0% | +2.9% above midpoint ($12.50) |
GMNA EBIT-Adj. — Q2 2026 | $3.18B | $3.23B | +1.6% | No explicit Q2 guidance | No explicit Q2 guidance | N/A | N/A |
GMNA EBIT-Adj. — FY 2026 | $12.45B | $12.71B | +2.1% | 8–10% NA margin (FY) | 8–10% NA margin (unchanged) | 0% | N/A — range guidance |
Total Revenue — Q2 2026 | $47.1B | $46.7B | -0.9% | No explicit guidance | No explicit guidance | N/A | N/A |
Total Revenue — FY 2026 | $186.3B | $185.3B | -0.5% | No explicit guidance | No explicit guidance | N/A | N/A |
Source: Visible Alpha Consensus and Actuals Data; GM Q1 2026 Earnings Call Transcript.
Commentary: The most notable revision dynamic is the sharp intra-quarter dip and recovery in Q2 EPS estimates — from ~$3.16 pre-Q1 earnings to a trough of ~$2.35 in May (as Iran conflict costs were digested), recovering to ~$3.20 by July. FY 2026 estimates have been remarkably stable near the raised guidance midpoint, suggesting the Street trusts GM’s full-year framework even if Q2 is expected to be the toughest quarter of the year.
Key Takeaway: GM has underperformed both the auto sector ETF (CARZ) and the S&P 500 since Q1 earnings, driven by multiple compression rather than estimate cuts — the Iran conflict overhang and commodity cost uncertainty have weighed on sentiment even as the underlying business has continued to execute.
GM vs. CARZ (Global Auto ETF) vs. S&P 500 (SPY) — Indexed to 100 at April 28, 2026 (Q1 2026 Earnings Date). Source: Yahoo Finance / Stock Price Data.
Performance Summary (Apr 28 – Jul 17, 2026): GM: -3.6% | CARZ (Global Auto ETF): +4.6% | S&P 500 (SPY): +4.4%. GM has lagged both benchmarks by approximately 8 percentage points since Q1 earnings. The underperformance is primarily multiple-driven: NTM P/E has compressed from ~6.1x to ~5.6x over the past quarter, while EV/EBITDA has moved from ~7.1x to ~6.9x. The stock briefly rallied to ~$84 in late May (likely on broader market strength and tariff optimism) before pulling back to the mid-$70s as Iran conflict concerns and commodity cost headwinds weighed on sentiment. At ~5.6x NTM P/E, GM trades at a deep discount to the S&P 500 (~22x) and even to historical automotive multiples, suggesting the market continues to apply a significant discount for cyclicality and EV transition risk.
Sector ETF: CARZ (First Trust NASDAQ Global Auto Index Fund) was used as the sector benchmark. It tracks global auto manufacturers and is the most appropriate sub-sector ETF for GM’s core business.
Source: Yahoo Finance / Stock Price Data; Stock Performance Decomposition Data.
Key Takeaway: The most important development since Q1 earnings is the Iran conflict’s escalating impact on commodity and logistics costs, which management has flagged as the primary variable for Q2 and the remainder of 2026. Separately, the ongoing tariff environment and Canada trade tensions add further macro uncertainty.
Key Takeaway: All insider transactions in the last 60 days are 10b5-1 planned sales — no discretionary open-market selling or buying. The pattern is consistent with pre-scheduled tax/liquidity management and does not signal any unusual insider view on the upcoming print.
Name | Title | Transaction Type | Value | Transaction Date | Note |
Mary T. Barra | Chair & CEO, Director | 10b5-1 Planned Sale | ~$7.5M (99,239 shares) | Jun 16, 2026 | Pre-scheduled 10b5-1 plan; not discretionary. |
Mary T. Barra | Chair & CEO, Director | 10b5-1 Planned Sale | ~$1.6M (20,582 shares) | Jun 9, 2026 | Pre-scheduled 10b5-1 plan; not discretionary. |
Paul A. Jacobson | EVP & CFO | 10b5-1 Planned Sale | ~$3.0M (40,000 shares) | May 26, 2026 | Pre-scheduled 10b5-1 plan; not discretionary. |
Rory Harvey | EVP | 10b5-1 Planned Sale | ~$0.7M (9,124 shares) | May 28, 2026 | Pre-scheduled 10b5-1 plan; not discretionary. |
Christopher Hatto | VP & CAO | 10b5-1 Planned Sale | ~$0.5M (6,895 shares) | May 28, 2026 | Pre-scheduled 10b5-1 plan; not discretionary. |
Source: SEC Form 4 Filings / Insider Transaction Data. All transactions are coded ‘S’ (sale/disposition) under pre-established 10b5-1 trading plans. No open-market discretionary buys or sells were filed in the last 60 days.
Key Takeaway: Peer commentary from the last 60 days points to three consistent themes relevant to GM’s Q2 2026 print: (1) raw material and logistics cost inflation is an industry-wide headwind beginning in Q2; (2) the North American truck/SUV market is becoming more competitive as Stellantis aggressively expands; and (3) the pricing environment is constrained, limiting the ability to pass through cost increases.
Note: Only commentary made in the last 60 days (on or after May 21, 2026) that pertains to Q2 2026 or the current/forward outlook is included below. Retrospective commentary on Q1 2025 or earlier results has been excluded.
Source: Stellantis Investor Day Transcript, May 21, 2026.
Source: Ford 8-K, July 2, 2026.
Source: Tesla 8-K, July 2, 2026.
Source: News Digest / CNN, July 12, 2026.
Source: Washington Post / News Digest, July 17–20, 2026.